← FDA Drug Approvals (Drugs@FDA)

JYLAMVO

NDA · New Drug Application · Sponsor: SHORLA · Approved 2022-11-29

Drug application

FDA Application #

NDA212479

Application type

New Drug Application

Brand name

JYLAMVO

Generic name

METHOTREXATE

Active ingredients

METHOTREXATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

SHORLA

Manufacturer

SHORLA ONCOLOGY INC.

First approval

2022-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown